Live from the NIH registry
Studies recruiting near South Lyon right now
Top 25 of 1,315 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Tr1X, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Associated Retinal Consultants PC — Royal Oak, Michigan (26.0 mi)
· Sponsor: Genentech, Inc.
Treatment of the Biceps With Concomitant Supraspinatus Tears
Supraspinatus Tear
N/A
Interventional 180 participants sought
Sports Medicine and Shoulder Surgery, University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: La Tour Hospital
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
C.S. Mott Children's Hospital — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Nationwide Children's Hospital
Prediction Augmented Screening Initiative
Lung Cancer, Lung Cancer Screening
N/A
Interventional 23,520 participants sought
VA Ann Arbor Healthcare System, Ann Arbor, MI — Ann Arbor, Michigan (13.5 mi)
· Sponsor: VA Office of Research and Development
HCMR Re-Imaging Study
Hypertrophic Cardiomyopathy (HCM)
N/A
Observational 314 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Christopher Kramer
RESET System Pivotal Trial (Rev F)
Diabetes type2, Obesity
N/A
Interventional 264 participants sought
Michigan Medicine, Division of Gastroenterology and Hepatology — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Morphic Medical Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Trinity Health Saint Joseph Mercy Hospital Ann Arbor — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
Invasive Mould Infection
Phase 2
Interventional 60 participants sought
U. of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Elion Therapeutics, Inc.
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
University of Michigan Health System — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Cook Research Incorporated
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
William Beaumont Hospital — Royal Oak, Michigan (26.0 mi)
· Sponsor: Synairgen Research Ltd.
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
Phase 2
Interventional 68 participants sought
GSK Investigational Site — Ann Arbor, Michigan (13.5 mi)
· Sponsor: GlaxoSmithKline
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Michigan Medicine - University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Crystalys Therapeutics
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
N/A
Interventional 24,000 participants sought
Henry Ford Medical Center-Columbus — Novi, Michigan (9.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Henry Ford Medical Center - Columbus — Novi, Michigan (9.1 mi)
· Sponsor: Eisai Inc.
Sacral Neuromodulation for Chronic Pelvic Pain
Chronic Pelvic Pain Syndrome
N/A
Interventional 25 participants sought
Corewell Health William Beaumont University Hospital — Royal Oak, Michigan (26.0 mi)
· Sponsor: Corewell Health East
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
University of Michigan Rogel Cancer Center — Ann Arbor, Michigan (13.5 mi)
· Sponsor: National Cancer Institute (NCI)
Quantitative MRI for Myelofibrosis
Myelofibrosis
N/A
Observational 192 participants sought
University of Michigan Hospital — Ann Arbor, Michigan (13.5 mi)
· Sponsor: University of Michigan Rogel Cancer Center
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
Michigan Headache & Neurological Institute — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Pfizer
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Invasive Candidiasis
N/A
Interventional 420 participants sought
CS Mott Children's Hospital — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Hematologic Malignancy, Solid Tumor
Phase 3
Interventional 50 participants sought
Uni Of Michigan Health System — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
Systemic Sclerosis
Phase 3
Interventional 92 participants sought
Local Institution - 0034 — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
Ventricular Tachycardia, Ischemic Cardiomyopathy
N/A
Interventional 100 participants sought
Medical University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Rush University Medical Center
Advancing Decisions About Virtual Service Encounters
Health Care Costs, Delivery of Health Care
N/A
Interventional 600 participants sought
VA Ann Arbor Healthcare System, Ann Arbor, MI — Ann Arbor, Michigan (13.5 mi)
· Sponsor: VA Office of Research and Development